US 7332471
Cross-linked glycopeptide-cephalosporin antibiotics
granted A61KA61K38/00A61P
Quick answer
US patent 7332471 (Cross-linked glycopeptide-cephalosporin antibiotics) held by Theravance, Inc. expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K38/00, A61P, A61P31/04